
Bionano Genomics, Inc. (BNGO) Q3 2025 Earnings Call Transcript
BNGO • NASDAQ
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold BNGO in your mock portfolio yet.
Bionano Genomics is currently unprofitable, as reflected in its negative EPS and PE ratio. The magnitude of the loss per share suggests a business still far from breakeven, with substantial execution and financing risk. Without evidence of improving margins or clear visibility to profitability, the financial profile is a headwind for the stock.
At $1.51, Bionano Genomics trades well below its 200-day moving average of $2.75, signaling a sustained downtrend. The RSI at 32.05 is near oversold territory, suggesting selling pressure has been strong, though it could also precede short-term bounces. Overall, the technical setup points to a weak trend with limited confirmation of a durable reversal.
Alternative data for Bionano Genomics show low but relatively stable engagement rather than strong growth or collapse. Website traffic and job postings are modest, and social media metrics are largely flat with small declines on some platforms and slight growth on LinkedIn. These signals neither strongly support a bullish growth narrative nor indicate an imminent deterioration, pointing to a neutral read-through.
Bionano Genomics’ stock currently reflects a combination of weak fundamentals and a technically damaged chart, with the share price well below its long-term moving average and the company still meaningfully unprofitable. Alternative data are largely flat and do not provide a strong counterbalance to the financial and technical risks. Overall, the setup leans bearish, with any potential upside likely dependent on future fundamental catalysts not visible in the current data.

Bionano Genomics, Inc. (BNGO) Q3 2025 Earnings Call Transcript



Bionano to Participate in the H.C. Wainwright @ Home Event
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: